TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
Pfizer Anti-Infectives AB
Closing information (x1000 EUR)
| Closing information | 2024/11 | 2023/11 | 2022/11 |
| Turnover |
158,571
|
185,053
|
123,850 |
| Financial expenses |
0
|
0
|
43 |
| Earnings before taxes |
94,093
|
88,416
|
37,997 |
| EBITDA |
88,421
|
91,235
|
43,458 |
| Total assets |
249,879
|
219,895
|
144,661 |
| Current assets |
8,558
|
5,826
|
10,283 |
| Current liabilities |
22,549
|
66,150
|
57,263 |
| Equity capital |
227,330
|
153,745
|
87,398 |
| - share capital |
4
|
4
|
5 |
| Employees (average) |
0
|
0
|
0 |
Financial ratios
| Fiscal year | 2024/11 | 2023/11 | 2022/11 |
| Solvency |
91.0%
|
69.9%
|
60.4% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
59.3%
|
47.8%
|
30.7% |
| Return on assets (ROA) |
37.7%
|
40.2%
|
26.3% |
| Current ratio |
38.0%
|
8.8%
|
18.0% |
| Return on equity (ROE) |
41.4%
|
57.5%
|
43.5% |
| Change turnover |
-25,081
|
66,666
|
93,601 |
| Change turnover % |
-14%
|
56%
|
309% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2024/11 | 2023/11 | 2022/11 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.